Nemes Rush Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-85
| Closed | -$5.79K | – | 743 |
|
|
2024
Q3 | $5.79K | Hold |
85
| – | – | ﹤0.01% | 450 |
|
|
2024
Q2 | $4.59K | Hold |
85
| – | – | ﹤0.01% | 468 |
|
|
2024
Q1 | $5.79K | Hold |
85
| – | – | ﹤0.01% | 486 |
|
|
2023
Q4 | $5.32K | Hold |
85
| – | – | ﹤0.01% | 479 |
|
|
2023
Q3 | $3.86K | Sell |
85
-1,831
| -96% | -$83.1K | ﹤0.01% | 496 |
|
|
2023
Q2 | $108K | Buy |
+1,916
| New | +$108K | 0.02% | 208 |
|